Skip to main content
Journal cover image

Clinical activity, safety and predictive biomarkers results from a phase Ia atezolizumab (atezo) trial in extensive-stage small cell lung cancer (ES-SCLC)

Publication ,  Journal Article
Sequist, LV; Chiang, A; Gilbert, J; Gordon, M; Conkling, PR; Thompson, D; Marcoux, JP; Antonia, SJ; Liu, B; Shames, DS; Lopez-Chavez, A ...
Published in: Annals of Oncology
October 1, 2016

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Annals of Oncology

DOI

EISSN

1569-8041

ISSN

0923-7534

Publication Date

October 1, 2016

Volume

27

Start / End Page

vi493

Related Subject Headings

  • Oncology & Carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sequist, L. V., Chiang, A., Gilbert, J., Gordon, M., Conkling, P. R., Thompson, D., … Gettinger, S. (2016). Clinical activity, safety and predictive biomarkers results from a phase Ia atezolizumab (atezo) trial in extensive-stage small cell lung cancer (ES-SCLC). Annals of Oncology, 27, vi493. https://doi.org/10.1093/annonc/mdw389.03
Sequist, L. V., A. Chiang, J. Gilbert, M. Gordon, P. R. Conkling, D. Thompson, J. P. Marcoux, et al. “Clinical activity, safety and predictive biomarkers results from a phase Ia atezolizumab (atezo) trial in extensive-stage small cell lung cancer (ES-SCLC).” Annals of Oncology 27 (October 1, 2016): vi493. https://doi.org/10.1093/annonc/mdw389.03.
Sequist LV, Chiang A, Gilbert J, Gordon M, Conkling PR, Thompson D, et al. Clinical activity, safety and predictive biomarkers results from a phase Ia atezolizumab (atezo) trial in extensive-stage small cell lung cancer (ES-SCLC). Annals of Oncology. 2016 Oct 1;27:vi493.
Sequist, L. V., et al. “Clinical activity, safety and predictive biomarkers results from a phase Ia atezolizumab (atezo) trial in extensive-stage small cell lung cancer (ES-SCLC).” Annals of Oncology, vol. 27, Oct. 2016, p. vi493. Scopus, doi:10.1093/annonc/mdw389.03.
Sequist LV, Chiang A, Gilbert J, Gordon M, Conkling PR, Thompson D, Marcoux JP, Antonia SJ, Liu B, Shames DS, Lopez-Chavez A, O’Hear C, Fasso M, Gettinger S. Clinical activity, safety and predictive biomarkers results from a phase Ia atezolizumab (atezo) trial in extensive-stage small cell lung cancer (ES-SCLC). Annals of Oncology. 2016 Oct 1;27:vi493.
Journal cover image

Published In

Annals of Oncology

DOI

EISSN

1569-8041

ISSN

0923-7534

Publication Date

October 1, 2016

Volume

27

Start / End Page

vi493

Related Subject Headings

  • Oncology & Carcinogenesis
  • 1112 Oncology and Carcinogenesis